Threshold for Transfusion in ACS: Still Room for Discretion Threshold for Transfusion in ACS: Still Room for Discretion
Cardiologists Michelle O ’Donoghue and Sunil Rao discuss more details from the MINT trial on a liberal vs conservative approach to blood transfusion in patients with anemia and acute coronary syndrome.theheart.org on Medscape (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - April 22, 2024 Category: Surgery Tags: Cardiology Commentary Source Type: news
You should get a colonoscopy if you have two common symptoms, even if you're under 50: Top GI cancer doctor
Dr James Cleary, a gastrointestinal oncologist at Dana-Farber cancer institute in Boston, warned that if you have anemia and unintended weight loss, you should get checked for colon cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - April 18, 2024 Category: Consumer Health News Source Type: news
SGLT2 Inhibitors Reduce Anemia Risk in Concomitant T2D, CKD SGLT2 Inhibitors Reduce Anemia Risk in Concomitant T2D, CKD
Initiating treatment with SGLT2 inhibitors vs GLP-1 RAs was linked to a 19% reduced risk for composite anemia outcomes in patients with T2D and CKD stages I-III.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 11, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Clinical Summary Source Type: news
Once-Rejected Drug Now FDA Approved for CKD-Related Anemia
(MedPage Today) -- The FDA approved vadadustat (Vafseo) for chronic kidney disease (CKD)-related anemia in adults who have been on dialysis for at least 3 months, developer Akebia Therapeutics announced on Wednesday.
"Patients receiving maintenance... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 28, 2024 Category: Hematology Source Type: news
U.S. FDA approves Akebia's anemia drug
(Source: Reuters: Health)
Source: Reuters: Health - March 28, 2024 Category: Consumer Health News Source Type: news
Two years after initial rejection, Akebia ’s anemia drug finally gets FDA approval
The FDA approved the Cambridge biotech's drug vadadustat for the treatment of anemia due to chronic kidney disease in adults who have been receiving dialysis for at least three months. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 28, 2024 Category: Biotechnology Authors: Hannah Green Source Type: news
FDA Approves Vafseo (vadadustat) for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
CAMBRIDGE, Mass., March 27, 2024 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the U.S. Food and Drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 27, 2024 Category: Drugs & Pharmacology Source Type: news
Child Malnutrition in Peru Driven Up by Poverty and Food Insecurity
A young Quechua mother, originally from Peru's southern Andes highlands, walks through the streets of Lima, carrying her young daughter in her lliclla (a colorful shawl made by native women in the Andes). A quarter of Peru's rural population under the age of five suffers from chronic malnutrition, clear evidence of inequality, which will have severe impacts on the rural child population. CREDIT: Wálter Hupiú / IPSBy Mariela JaraLIMA, Mar 27 2024 (IPS) Quechua farmer Felipa Noamesa, who lives in the southern Peruvian department of Cuzco, prepares a cream of fava bean soup for breakfast every morning with bread and vegetab...
Source: IPS Inter Press Service - Health - March 27, 2024 Category: International Medicine & Public Health Authors: Mariela Jara Tags: Development & Aid Economy & Trade Editors' Choice Featured Financial Crisis Food and Agriculture Headlines Health Humanitarian Emergencies Latin America & the Caribbean Population Poverty & SDGs Regional Categories TerraViva Unit Source Type: news
Sex-specific association between maternal mild anemia and children's behavioral development: a birth cohort study - Hao X, Guo Y, Lu J, Zhu L, Yan S, Tao F, Huang K.
There has been limited research on maternal anemia affecting children's behavioral development, with a lack of studies focusing on sex differences in this association. Based on the Ma'anshan Birth Cohort, 2132 mother-child pairs were included. Maternal ane... (Source: SafetyLit)
Source: SafetyLit - March 25, 2024 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
The Tea Shops Bubbling Up Hong Kong's Anemic IPO Market
Hong Kong’s IPO market was once the biggest in the world. Now, its great hope is bubble tea with at least four Chinese stores that sell bubble tea preparing to go public in the city, where nine companies have listed shares so far this year.#hongkongs (Source: Reuters: Health)
Source: Reuters: Health - March 22, 2024 Category: Consumer Health News Source Type: news
Iptacopan Improves Hematologic, Clinical Outcomes in Persistent Anemia
TUESDAY, March 19, 2024 -- The first-in-class oral factor B inhibitor iptacopan improves hematologic and clinical outcomes in anti-C5-treated patients with persistent anemia and in those who have not received complement inhibitors, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 19, 2024 Category: Pharmaceuticals Source Type: news
Many Children With Sickle Cell Anemia Do Not Meet Quality Indicators
MONDAY, March 18, 2024 -- A number of children with sickle cell anemia (SCA) have low rates of receipt of recommended antibiotic prophylaxis and annual transcranial Doppler (TCD) ultrasound, according to a study published online March 6 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 18, 2024 Category: Pharmaceuticals Source Type: news
Chemo robbed me of my sight - but I'm determined to run the London Marathon
Police officer Kate Duckers thought she was just anaemic until doctors gave her a shocking cancer diagnosis. Then the treatment meant to save her left her blind (Source: Daily Express - Health)
Source: Daily Express - Health - March 18, 2024 Category: Consumer Health News Source Type: news
FDA Panel Endorses Imetelstat for MDS-Related Anemia
(MedPage Today) -- An FDA panel overwhelmingly backed investigational imetelstat as a treatment option for transfusion-dependent anemia in adults with lower-risk myelodysplastic syndromes (MDS) who failed on erythropoiesis-stimulating agents (ESAs... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 14, 2024 Category: American Health Source Type: news
FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemia
(MedPage Today) -- FDA staff appear to have serious doubts about the prospects of imetelstat as a treatment for transfusion-dependent anemia in adults with myelodysplastic syndromes (MDS), according to a briefing document released ahead of a meeting... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 12, 2024 Category: American Health Source Type: news
